Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic biomarkers as strong correlates of Parkinson disease progression
Peter A. LeWitt, Jia Li, Mei Lü, et al.
Neurology (2017) Vol. 88, Iss. 9, pp. 862-869
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
Eleanor Sinclair, Drupad K. Trivedi, Depanjan Sarkar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 152
The Potential of Metabolomics in Biomedical Applications
Vanessa González-Covarrubias, Eduardo Martínez‐Martínez, Laura del Bosque‐Plata
Metabolites (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 134
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
Emrin Horgusluoglu, Ryan Neff, Won‐Min Song, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 6, pp. 1260-1278
Open Access | Times Cited: 111
The Crosstalk between Gut Microbiota and Nervous System: A Bidirectional Interaction between Microorganisms and Metabolome
Monica Montagnani, Lucrezia Bottalico, Maria Assunta Potenza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10322-10322
Open Access | Times Cited: 59
Elucidation of complexity and prediction of interactions in microbial communities
Cristal Zúñiga, Lívia S. Zaramela, Karsten Zengler
Microbial Biotechnology (2017) Vol. 10, Iss. 6, pp. 1500-1522
Open Access | Times Cited: 138
Biomarker Research in Parkinson’s Disease Using Metabolite Profiling
Jesper F. Havelund, Niels H. H. Heegaard, Nils J. Færgeman, et al.
Metabolites (2017) Vol. 7, Iss. 3, pp. 42-42
Open Access | Times Cited: 131
Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
Yiwei Qian, Xiaodong Yang, Shaoqing Xu, et al.
Brain (2020) Vol. 143, Iss. 8, pp. 2474-2489
Open Access | Times Cited: 108
Targeting mitophagy in Parkinson's disease
Emily H. Clark, Aurelio Vázquez de la Torre, Tamaki Hoshikawa, et al.
Journal of Biological Chemistry (2020) Vol. 296, pp. 100209-100209
Open Access | Times Cited: 96
Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
Anna Picca, Flora Guerra, Riccardo Calvani, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1508-1508
Open Access | Times Cited: 93
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
Daniel Stoessel, Claudia Schulte, Márcia Cristina Teixeira dos Santos, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 90
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
Motoki Fujimaki, Shinji Saiki, Yuanzhe Li, et al.
Neurology (2018) Vol. 90, Iss. 5
Open Access | Times Cited: 89
Serum amino acid profile in patients with Parkinson’s disease
Monika Figura, Katarzyna Kuśmierska, Ewelina Bucior, et al.
PLoS ONE (2018) Vol. 13, Iss. 1, pp. e0191670-e0191670
Open Access | Times Cited: 85
Update on CSF Biomarkers in Parkinson’s Disease
Eun Hae Kwon, Sabrina Tennagels, Ralf Gold, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 329-329
Open Access | Times Cited: 53
Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
Szu‐Ju Chen, Chin‐Hsien Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 53
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16119-16119
Open Access | Times Cited: 30
Metabolomics in Parkinson’s Disease and Correlation with Disease State
Elena A. Ostrakhovitch, Kenjiro Ono, Tritia R. Yamasaki
Metabolites (2025) Vol. 15, Iss. 3, pp. 208-208
Open Access | Times Cited: 1
Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
Desiree Willkommen, Marianna Lucio, Franco Moritz, et al.
PLoS ONE (2018) Vol. 13, Iss. 12, pp. e0208752-e0208752
Open Access | Times Cited: 75
Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson’s Disease Reveals Distinct Metabolic Profiles
Stewart F. Graham, Nolwen L. Rey, Ali Yilmaz, et al.
Journal of Proteome Research (2018) Vol. 17, Iss. 7, pp. 2460-2469
Open Access | Times Cited: 66
Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson’s disease and healthy controls
Sadhana Kumari, Vinay Goyal, S Senthil Kumaran, et al.
Neurological Sciences (2020) Vol. 41, Iss. 5, pp. 1201-1210
Closed Access | Times Cited: 65
A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
Stephan Klatt, James D. Doecke, Anne Roberts, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson’s Disease
Szu‐Ju Chen, Chieh‐Chang Chen, Hsin-Yu Liao, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 4, pp. 1219-1230
Closed Access | Times Cited: 29
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
Ilham Y. Abdi, Michael Bartl, Mohammed Dakna, et al.
Neurobiology of Disease (2023) Vol. 177, pp. 105997-105997
Open Access | Times Cited: 17
Utilization of diverse probiotics to create human health promoting fatty acids: A review
Kuang He, Hao Cheng, David Julian McClements, et al.
Food Chemistry (2024) Vol. 458, pp. 140180-140180
Closed Access | Times Cited: 8
Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort
Nourhan Shebl, Shaimaa I El-Jaafary, Ayman A. Saeed, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 7
Metabolomics‐based identification of metabolic alterations in PARK2
Ayami Okuzumi, Taku Hatano, Shinichi Ueno, et al.
Annals of Clinical and Translational Neurology (2019) Vol. 6, Iss. 3, pp. 525-536
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top